In a new 13G filing just reported to the SEC, John W. Rogers‘ Ariel Investments has disclosed a 10.9% stake in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX). Shares are up slightly on the news, but due to the passive nature of the filing, don’t expect Rogers to push for any meaningful changes at Cumberland. Rather, he’s on the ride for the appreciation potential.
Recommended Reading:
First Eagle Unloads Some Alliant Techsystems
Ariel Investments Ups Position in American Electric Technologies to 11.8%
Why Ricky Sandler Gave The Men’s Wearhouse a Lesson in M&A 101
